Republished from ALPA FastRead on August 6, 2020
Clinical trials to evaluate potential vaccines to prevent COVID-19 are underway in multiple countries, including the United States and Canada. These trials utilize volunteers to test the ability of the vaccine to induce antibodies to prevent either symptomatic or nonsymptomatic COVID-19. A secondary goal of the vaccine trials is to evaluate the overall safety or potential side effects of the vaccine on a participant.
While volunteering to participate in a vaccine trial may seem worthwhile, participation would result in a pilot being grounded. ALPA has confirmed that both the Federal Aviation Administration (FAA) and Transport Canada (TC) are still researching the need for a wait time prior to flight duty after individuals receive any experimental vaccine. Until they formally announce guidance, the FAA and TC have suggested that pilots receiving any experimental vaccines could be required to self-ground.
ALPA continues to closely follow this issue and will provide updates on pilot use of developmental COVID-19 vaccines as they are available.